BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12228775)

  • 1. Utilization and outcomes of the implantable cardioverter defibrillator, 1987 to 1995.
    Hlatky MA; Saynina O; McDonald KM; Garber AM; McClellan MB
    Am Heart J; 2002 Sep; 144(3):397-403. PubMed ID: 12228775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and cost-effectiveness of implantable cardioverter defibrillators in the treatment of ventricular arrhythmias among medicare beneficiaries.
    Weiss JP; Saynina O; McDonald KM; McClellan MB; Hlatky MA
    Am J Med; 2002 May; 112(7):519-27. PubMed ID: 12015242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in hospital treatment of ventricular arrhythmias among Medicare beneficiaries, 1985 to 1995.
    McDonald KM; Hlatky MA; Saynina O; Geppert J; Garber AM; McClellan MB
    Am Heart J; 2002 Sep; 144(3):413-21. PubMed ID: 12228777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implantable cardioverter defibrillator utilization based on discharge diagnoses from Medicare and managed care patients.
    Ruskin JN; Camm AJ; Zipes DP; Hallstrom AP; McGrory-Usset ME
    J Cardiovasc Electrophysiol; 2002 Jan; 13(1):38-43. PubMed ID: 11843481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes in patients with sustained ventricular tachyarrhythmias occurring within 48 h of acute myocardial infarction: when is ICD appropriate?
    Liang JJ; Hodge DO; Mehta RA; Russo AM; Prasad A; Cha YM
    Europace; 2014 Dec; 16(12):1759-66. PubMed ID: 25100756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implantable Cardioverter-Defibrillator Use Among Medicare Patients With Low Ejection Fraction After Acute Myocardial Infarction.
    Pokorney SD; Miller AL; Chen AY; Thomas L; Fonarow GC; de Lemos JA; Al-Khatib SM; Peterson ED; Wang TY
    JAMA; 2015 Jun 23-30; 313(24):2433-40. PubMed ID: 26103027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term morbidity and mortality after implantable cardioverter-defibrillator implantation with procedural complication: A report from the National Cardiovascular Data Registry.
    Kipp R; Hsu JC; Freeman J; Curtis J; Bao H; Hoffmayer KS
    Heart Rhythm; 2018 Jun; 15(6):847-854. PubMed ID: 28987459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal trends in patient characteristics and outcomes among Medicare beneficiaries undergoing primary prevention implantable cardioverter-defibrillator placement in the United States, 2006-2010. Results from the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.
    Borne RT; Peterson PN; Greenlee R; Heidenreich PA; Wang Y; Curtis JP; Tzou WS; Varosy PD; Kremers MS; Masoudi FA
    Circulation; 2014 Sep; 130(10):845-53. PubMed ID: 25095884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Spanish implantable cardioverter-defibrillator registry. Seventh official report of the spanish society of cardiology working group on implantable cardioverter-defibrillators (2010)].
    Alzueta J; Fernández JM
    Rev Esp Cardiol; 2011 Nov; 64(11):1023-34. PubMed ID: 21967881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of ventricular arrhythmias in diverse populations in California.
    Alexander M; Baker L; Clark C; McDonald KM; Rowell R; Saynina O; Hlatky MA
    Am Heart J; 2002 Sep; 144(3):431-9. PubMed ID: 12228779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reassessment of Cardiac Function and Implantable Cardioverter-Defibrillator Use Among Medicare Patients With Low Ejection Fraction After Myocardial Infarction.
    Pokorney SD; Miller AL; Chen AY; Thomas L; Fonarow GC; de Lemos JA; Al-Khatib SM; Velazquez EJ; Peterson ED; Wang TY
    Circulation; 2017 Jan; 135(1):38-47. PubMed ID: 27881561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of risk stratification on cost-effectiveness of the implantable cardioverter defibrillator.
    Owens DK; Sanders GD; Heidenreich PA; McDonald KM; Hlatky MA
    Am Heart J; 2002 Sep; 144(3):440-8. PubMed ID: 12228780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the implantable cardioverter-defibrillator on rehospitalizations.
    Valenti R; Schlåpfer J; Fromer M; Fischer A; Kappenberger L
    Eur Heart J; 1996 Oct; 17(10):1565-71. PubMed ID: 8909915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spanish Implantable Cardioverter-defibrillator Registry. Ninth official report of the Spanish Society of Cardiology Electrophysiology and Arrhythmias Section (2012).
    Alzueta J; Fernández JM
    Rev Esp Cardiol (Engl Ed); 2013 Nov; 66(11):881-93. PubMed ID: 24773996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The frequency and incremental cost of major complications among medicare beneficiaries receiving implantable cardioverter-defibrillators.
    Reynolds MR; Cohen DJ; Kugelmass AD; Brown PP; Becker ER; Culler SD; Simon AW
    J Am Coll Cardiol; 2006 Jun; 47(12):2493-7. PubMed ID: 16781379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real world effectiveness of primary implantable cardioverter defibrillators implanted during hospital admissions for exacerbation of heart failure or other acute co-morbidities: cohort study of older patients with heart failure.
    Chen CY; Stevenson LW; Stewart GC; Bhatt DL; Desai M; Seeger JD; Williams L; Jalbert JJ; Setoguchi S
    BMJ; 2015 Jul; 351():h3529. PubMed ID: 26174233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-chamber versus dual-chamber implantable cardioverter defibrillators: indications and clinical results.
    Trappe HJ; Achtelik M; Pfitzner P; Voigt B; Weismüller P
    Am J Cardiol; 1999 Mar; 83(5B):8D-16D. PubMed ID: 10089834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to the Center for Medicare & Medicaid Services coverage with evidence development request for primary prevention implantable cardioverter-defibrillators: data from the OMNI study.
    Sweeney MO; Sakaguchi S; Simons G; Machado C; Connett JE; Yang F;
    Heart Rhythm; 2012 Jul; 9(7):1058-66. PubMed ID: 22387371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infection and mortality after implantation of a subcutaneous ICD after transvenous ICD extraction.
    Boersma L; Burke MC; Neuzil P; Lambiase P; Friehling T; Theuns DA; Garcia F; Carter N; Stivland T; Weiss R;
    Heart Rhythm; 2016 Jan; 13(1):157-64. PubMed ID: 26341604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.